Key result
Major blood vessel reconstruction during sarcoma surgery achieved 58% primary arterial patency, 78% venous patency, and 68% 5-year overall survival, with limb salvage in 93% of patients.
Why the study?
What are the outcomes of major vessel reconstruction as part of surgery to remove sarcomas?
Observational (n=14)
No
What are the outcomes of major vessel reconstruction as part of surgery to remove sarcomas?
Major blood vessel reconstruction during sarcoma resection is feasible and achieves acceptable graft patency and survival rates, indicating vascular involvement is not an absolute contraindication to surgery.
May support vessel reconstruction for limb salvage in select sarcomas; leaves open prospective validation before broader adoption.
OBJECTIVE: To evaluate the outcomes of major vessel reconstruction as part of surgery to remove sarcomas. DESIGN: Retrospective review. SETTING: Tertiary academic medical center. PATIENTS: Fourteen patients (10 female) with retroperitoneal or extremity sarcomas and major blood vessel involvement who underwent surgery to remove the tumor and had blood vessel reconstruction between 2003 and 2008. Each patient underwent computed tomography angiography. MAIN OUTCOME MEASURES: Early (<30 days) and late (>30 days) operative morbidity and mortality, freedom from disease, and graft patency. RESULTS: Seven patients had retroperitoneal sarcomas and 7, extremity sarcomas. Thirteen tumors were malignant (7 high grade and 6 low grade) and 1, benign (leiomyoma). Seven patients had replacement of artery and vein; 5, artery only; and 2, vein only. In all, 16 arteries were reconstructed (2 common femoral; 5 iliac; 2 superficial femoral; 1 brachial; 1 popliteal; and 2 aorta, one with implantation of both iliac arteries and the other with implantation of the left renal, superior mesenteric, and hepatic arteries). Eight patients (57%) had 9 veins reconstructed (3 external iliac, 3 superficial femoral, 2 vena cava, and 1 popliteal). Primary arterial patency was 58% and primary-assisted patency was 83%. Venous patency was 78%. Local recurrence occurred in 3 patients (21%). Five-year disease-free and overall survival were 52% and 68%, respectively. Limb salvage was achieved in 93%. CONCLUSION: Involvement of vascular structures is not a contraindication for resection of sarcomas, but appropriate planning is necessary to optimize outcome.
No takes yet. Share an insight, caveat, or question.
Tae K. Song (2009) conducted an observational in Retroperitoneal or extremity sarcomas with major blood vessel involvement (n=14). Major blood vessel reconstruction was evaluated on Early (<30 days) and late (>30 days) operative morbidity and mortality, freedom from disease, and graft patency. Major blood vessel reconstruction during sarcoma surgery achieved 58% primary arterial patency, 78% venous patency, and 68% 5-year overall survival, with limb salvage in 93% of patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: